Alkermes plc (8AK.F) Stock Price, News & Chart

	8AK.F	NBIX	4119.TW	AMRX	AMLX	ALVO
Market cap	6.64B	16.81B	6.05B	6.95B	3.69B	1.67B
P/E (TTM)	—	24.6	99.2	49.9	—	—
Forward P/E	31.1	13.9	9.0	16.4	-27.0	20.3
Price/book	4.0	4.3	1.1	12.6	13.7	-8.7
Dividend yield	—	—	1.47%	—	—	—
1-year change	+52.65%	+7.27%	−9.43%	+71.10%	+135.96%	−7.71%
Today	−1.99%	+0.73%	−0.59%	−1.29%	+0.68%	+2.86%

Market cap

6.64B

16.81B

6.05B

6.95B

3.69B

1.67B

P/E (TTM)

—

24.6

99.2

49.9

—

Forward P/E

31.1

13.9

9.0

16.4

-27.0

20.3

Price/book

4.0

4.3

1.1

12.6

13.7

-8.7

Dividend yield

—

1.47%

—

1-year change

+52.65%

+7.27%

−9.43%

+71.10%

+135.96%

−7.71%

Today

−1.99%

+0.73%

−0.59%

−1.29%

+0.68%

+2.86%

Company	Mkt cap	Price	Today
Neurocrine Biosciences, Inc.NBIX · Drug Manufacturers - Specialty & Generic	16.81B	166.05	+0.73%
SCI Pharmtech, Inc.4119.TW · Drug Manufacturers - Specialty & Generic	6.05B	50.60	−0.59%
Amneal Pharmaceuticals, Inc.AMRX · Drug Manufacturers - Specialty & Generic	6.95B	19.95	−1.29%
Amylyx Pharmaceuticals, Inc.AMLX · Drug Manufacturers - Specialty & Generic	3.69B	29.40	+0.68%
AlvotechALVO · Drug Manufacturers - Specialty & Generic	1.67B	4.6700	+2.86%
Aquestive Therapeutics, Inc.AQST · Drug Manufacturers - Specialty & Generic	477.61M	3.8000	−2.06%
Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGS.NS · Drug Manufacturers - Specialty & Generic	3.49B	109.38	+0.08%
iX Biopharma Ltd.42C.SI · Drug Manufacturers - Specialty & Generic	515.12M	0.4700	−3.09%

Company	Mkt cap	Price	Today
Wanbury LimitedWANBURY.BO · Navi Mumbai, India	6.52B	186.40	−3.19%
KPC Pharmaceuticals,Inc.600422.SS · Kunming, China	6.71B	8.86	+1.61%
HARBIN GLORIA PHARMACEUTICALS Co., LTD002437.SZ · Harbin, China	6.82B	3.0600	+2.34%
Lantheus Holdings, Inc.LNTH · Bedford, MA	6.60B	101.14	+0.34%
Jiangsu Kanion Pharmaceutical Co.,Ltd.600557.SS · Lianyungang, China	7.26B	12.83	+0.39%
Jiuzhitang Co., Ltd.000989.SZ · Beijing, China	7.34B	8.57	+1.66%
Guangxi Wuzhou Zhongheng Group Co., Ltd600252.SS · Wuzhou, China	7.13B	2.2400	+2.28%
Gedeon Richter PLCRIG2.F · Budapest, Hungary	6.44B	35.30	−1.94%

Company	Mkt cap	Price	Today
Wanbury LimitedWANBURY.BO · Drug Manufacturers - Specialty & Generic	6.52B	186.40	−3.19%
Bio-Thera Solutions, Ltd.688177.SS · Biotechnology	7.38B	17.82	+2.95%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology	6.67B	40.15	−0.67%
BeBetter Med Inc.688759.SS · Biotechnology	7.56B	16.79	+4.42%
China Reform Health Management and Services Group Co., Ltd.000503.SZ · Healthcare Plans	7.07B	7.22	+3.88%
KPC Pharmaceuticals,Inc.600422.SS · Drug Manufacturers - Specialty & Generic	6.71B	8.86	+1.61%
HARBIN GLORIA PHARMACEUTICALS Co., LTD002437.SZ · Drug Manufacturers - Specialty & Generic	6.82B	3.0600	+2.34%
Getinge AB (publ)GTN0.F · Medical Devices	7.01B	25.00	+3.31%

Company	Mkt cap	Price	Today
Accenture plcACN · Dublin, Ireland	161.72B	264.27	+3.81%
Eaton Corporation plcETN · Dublin, Ireland	137.17B	353.08	−9.86%
PDD Holdings Inc.PDD · Dublin, Ireland	116.93B	82.15	+2.47%
Aon plcAON · Dublin, Ireland	73.12B	344.67	+4.39%
CRH plcCRH · Dublin, Ireland	65.72B	98.80	+5.63%
Experian plcJ2B.F · Dublin, Ireland	32.24B	36.80	+2.22%
AerCap Holdings N.V.AER · Dublin, Ireland	25.17B	165.72	+2.04%
AIB Group plcA5G.IR · Dublin, Ireland	24.48B	11.69	+0.69%

Company	Mkt cap	Price	Today
Ipsen S.A.I7G.F · life sciences · healthcare	12.79B	155.20	+2.04%
H. Lundbeck A/S0ND5.IL · life sciences · healthcare	55.31B	55.20	+0.36%
Dermapharm Holding SEDMP.DE · life sciences · healthcare	1.92B	38.85	−0.13%
Morepen Laboratories LimitedMOREPENLAB.BO · life sciences · healthcare	53.04B	96.80	−3.44%
Swedish Orphan Biovitrum AB (publ)0MTD.IL · life sciences · healthcare	178.69B	493.90	+2.36%
Zhejiang Hisun Pharmaceutical Co., Ltd.600267.SS · life sciences · healthcare	16.32B	13.83	+3.29%
Hikma Pharmaceuticals PLCH5P.F · life sciences · healthcare	4.24B	20.50	−2.38%
GC Biopharma Corp.006280.KS · life sciences · healthcare	1.62T	142,300.00	+2.67%

Company	Mkt cap	Price	Today
Acadia Pharmaceuticals Inc.DR6.F · Correlation 0.33	3.26B	18.94	+2.85%

Company	Mkt cap	Price	Today
Halozyme Therapeutics Inc.RV7.F	13.05B	115.00	+1.23%
Incyte Corp.ICY.F	22.13B	108.55	+4.83%
ACADIA PHARMACEUTICALS INC.DR6.F	3.26B	18.94	+2.85%
NEUROCRINE BIOSCIENCES INC.NB3.F	14.69B	145.15	+0.10%
Sarepta Therapeutics Inc.AB3A.F	1.76B	16.62	+2.34%

24/7 Wall St.·1d agoNegative

Alkermes Q3 2026: Revenue Beats, Avadel Costs Leave EPS Missing Expectations

As seen on the 24/7 Wall St. homepage on November 3, 2026. The earnings miss came from $29.8 million of Avadel deal costs, while revenue topped expectations and newly acquired LUMRYZ contributed in its first full quarter. Management…

ALKS ALNY

Seeking Alpha·1d agoPositive

Alkermes reiterates $400M-$420M Q4 proprietary net sales outlook while targeting mid-2027 alixorexton Phase III data

Alkermes Q3 2026 earnings: LUMRYZ growth, strong revenue, 2026 guidance, and pipeline updates in narcolepsy and MDD. Earnings Call Insights: Alkermes (ALKS) Q3 2026 “On my first quarterly call as CEO of Alkermes, I’d like to start with a…

ALKS BAC

BioSpace·1d agoPositive

Alkermes to Present at Upcoming Investor Conferences

BioSpace Alkermes to Present at Upcoming Investor Conferences DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences. Stifel 2026 Healthcare Conference…

ALKS

BioSpace·1d agoPositive

Alkermes plc Reports Third Quarter 2026 Financial Results

BioSpace Alkermes plc Reports Third Quarter 2026 Financial Results About Alkermes plc Alkermes plc (Nasdaq: ALKS), a mid-cap growth and value equity, is a global biopharmaceutical company that seeks to develop innovative medicines in the…

ALKS ALKT

Seeking Alpha·1d agoPositive

Alkermes plc (ALKS) Q3 2026 Earnings Call Transcript

Alkermes plc (ALKS) Q3 2026 Earnings Call November 3, 2026 8:00 AM ESTCompany ParticipantsSandra Coombs - Senior Vice President of Corporate Affairs &... Alkermes plc (ALKS) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Sandra Coombs…

ALKS MS BAC

Milk Road·1d agoPositive

Alkermes plc (ALKS) — Milk Road

Alkermes plc (ALKS) Milk Road Curated stocks and crypto, ranked by analyst ratings, social buzz and fundamentals. Filter by theme to find your next idea. Nov 3, 2026 (9:10 PM UTC)Nov 3, 2026 · 9:10 PM UTC

ALKS ALK AOMFF ALKT

Seeking Alpha·2d agoPositive

Alkermes Q3 2026 Earnings Preview

Preview Alkermes Q3 earnings before market open on November 3, with consensus EPS, revenue growth, and past earnings beat trends. - Alkermes (ALKS) is scheduled to announce Q3 earnings results on Tuesday, November 3rd, before market open.…

ALKT ALB ALKS

MarketScreener·2d agoPositive

Alkermes Initiates Phase 2 Study of Alks 7290 as Adjunctive Treatment for Major Depressive Disorder

Alkermes initiated a phase 2 study evaluating the safety and efficacy of ALKS 7290 as an adjunctive therapy to antidepressants in adult participants with major depressive disorder . ALKS 7290 is the... Alkermes initiated a phase 2 study…

ROG ALKS JNJ LLY

Markets Daily·5d agoPositive

Head to Head Contrast: Opus Genetics (NASDAQ:IRD) versus Alkermes (NASDAQ:ALKS)

Posted by Mitch Edgeman on Oct 31st, 2026 Opus Genetics (NASDAQ:IRD – Get Free Report) and Alkermes (NASDAQ:ALKS – Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based…

IRD VBIO ALLR

@PRNewswire·Oct 19Positive

Alkermes Announces Positive Phase 1b Results Demonstrating Clinical Proof-of-Concept for ALKS 7290 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

— ALKS 7290 is the First Orexin 2 Receptor Agonist to Demonstrate Clinically Meaningful Improvements in ADHD Symptoms in Adults — — ALKS 7290 Was Generally Well Tolerated at All Doses Tested in Healthy Volunteers and Adults With ADHD — —…

ALKS LFST LLY CUE

Days on the list

30 d

1 yr

Best

Trending

—

Install

Alkermes plc

Key statistics

Against its peers

Latest news